Skip to content
AKBA Akebia Therapeutics, Inc.
$1.04 0.00% 0.00
Notify me if price changes either direction
Interactive Brokers Logotype

Buy AKBA stocks now with Interactive Brokers – the most advanced investment platform

Contents
  • Performance
  • Key stats
  • Financials
  • US politician trades
Loading

Key Stats

Market cap. 273.6M
Enterprise value 316.6M
Trailing PE -51.249998807907
Forward PE -5.4210525
PEG Ratio 0.25624999403954
Enterprise to EBITDA 26.097
Enterprise to revenue 1.362
Price to book MRQ 10.098039
Price to sales TTM 1.1889037

Financials

Fiscal Year Ends 2025-12-31
Most Recent Quarter (MRQ) 2026-03-31
Revenue (TTM) 232.4M
EBITDA 24.8M
Diluted EPS TTM -0.08
Total Cash (MRQ) 162.6M
Current ratio (MRQ) 1.4
Operating Cash Flow (TTM) 60.4M

AKBA trades by the US politicians

Percentage
0% 0 sells
100% 0 buys
Amount
$0 0 sells
$0 0 buys
In the last 0 months

Recent AKBA News

Home

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.